Revolving Door: DEA’s No.2 quits amid reports of previous consulting work for Big Pharma
Headline from WHEC Rochester
The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he previously consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became the…
WHEC Rochester's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he previously consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became the…
WASHINGTON >> The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he once consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that be…
The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he once consulted for a pharmaceutical distributor sanctioned for a deluge of suspicious painkiller shipments and did similar work for the drugmaker that became the face …
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Revolving Door: DEA’s No.2 quits amid reports of previous consulting work for Big Pharma | Since Then
